With the rising prevalence geriatric population and growing incidence of blood disorders such as leukemia, myeloma, cancer and other infectious diseases the demand for hematology diagnostic is augmenting. Also, increasing awareness for these diseases with its diagnosis and screening in hospitals and ambulatory centers are other major contributors in the growth of hematology diagnostics during 2020-25.
According to the MarkNtel Advisors’ research report, the CAGR of “Global Hematology Diagnostics Market Analysis, 2020”, is expected to be around 5.8% during 2020-25 on account of the increasing government healthcare spending in Asia-Pacific, Europe, Middle East to improve the healthcare infrastructure and provide better health facilities.
Moreover, the emergence of high end private hospital chains is the new trend globally where latest and quality high end diagnostic instruments are used to monitor the patients. Thus, rise in ambulatory centers and hospitals is contributing significantly to the global hematology diagnostics market and is further estimated to amplify during 2020-25.
Rising Blood Disorders Mushrooming the Hematology Diagnostics Market
With the growing opportunities for healthcare services and mounting blood disorders in millennials is resulting into the demand for hematology diagnostics in hospitals and ambulatory centers. Moreover, rising medical infrastructure investments in the healthcare sector by governments and enhancing medical facilities is also contributing in the growth of hematology diagnostics market in recent years.
In 2019, hematology analyzers grabbed a substantial market share owing to the introduction of fully automated analyzers that are cost effective with enhanced performance in past years. These analyzers detect typical results and can measure red cell distribution, nucleated red cell counts and Reticulocyte counts.
Asia-Pacific is a lucrative market for the growth of hematology diagnostics on account of large population and exponential rise in health disorders among individuals. North America is the leading market for the hematology diagnostics and grabbed the largest market share in 2019 especially US and Canada on account of availability of improved healthcare medical facilities offers immense growth for revenue growth as revealed by MarkNtel Advisors’ in their research report, “Global Hematology Diagnostics Market Analysis, 2020”.
According to the MarkNtel Advisors the major leading players are Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Symex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. among others. Danaher Corporation launched CE mark approval for DxH 520 hematology analyzer.
Companies are merging, acquiring business and launching new products for the enhancements of hospitals thereby surging the hematology diagnostics market. Abbott Laboratories launched CP3000 coagulation analyzer by Sekisui Diagnostics in Asia-Pacific, Europe and Middle East in 2017. ERBA Group launched new hematology analyzers at MEDLAB in 2019. Its latest H360 and H 560 are designed to improve lab efficiency targeting small and medium enterprises.
“Global Hematology Diagnostics Market Analysis, 2020”, provides comprehensive qualitative and quantitative insights on the industry potential, key factors such as trends, drivers, hotspots and opportunities and challenges available for hematology diagnostics providers across the globe. Moreover, the report also encompasses the key leading players in the industry, along with competitive benchmarking and competition matrix and company profiling.
1. By Product Type (Hematology Instruments, Hematology Analyzer, Fully-automated hematology analyzer, Semi-automated hematology analyzer, Flow cytometers, Others)
2. By End User (Hospitals and Clinics, Diagnostic Laboratories, Academic Institute, Commercial Service Providers, Others)
3. By Consumables (Reagents, Stains, Controls and Calibrations, Others)
4. By Region (North America, Latin America, Europe, Middle East and Africa and Asia-Pacific)
5. By Country (United States, Canada, Mexico, Brazil, Argentina, Germany, Italy, United Kingdom, Spain, France, Saudi Arabia, UAE, China, India, Japan, Australia, South Korea)
6. By Company (Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Symex Corporation, Nihon Kohden Corpration, Danaher Corporation, F. Hoffman-La-Roche Ltd.)